HROW is currently covered by 6 analysts with an average price target of $69.2. This is a potential upside of $40.11 (137.88%) from yesterday's end of day stock price of $29.09.
Harrow Health's activity chart (see below) currently has 72 price targets and 67 ratings on display. The stock rating distribution of HROW is 100% BUY.
Analysts' price targets on this stock were met 45.13% of the time, taking 218.24 days on average.
Highest price target for HROW is $91, Lowest price target is $60, average price target is $69.2.
Most recent stock forecast was given by THOMAS SHRADER from BTIG. First documented stock forecast 10-Dec-2018.
Currently out of the existing stock ratings of HROW, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Jun-2025
$63
$32.88 (109.16%)
$63
6 days ago
(11-Nov-2026)
Buy Since 15-May-2024
$60
$29.88 (99.20%)
$65
6 months 3 days ago
(14-May-2026)
4/10 (40%)
$29.14 (94.43%)
112
$88
$57.88 (192.16%)
$91
6 months 4 days ago
(13-May-2026)
0/4 (0%)
$58.17 (195.01%)
Buy Since 06-Feb-2025
$70
$39.88 (132.40%)
$70
7 months 29 days ago
(19-Mar-2026)
0/10 (0%)
$35.59 (103.43%)
Buy Since 10-Dec-2018
$60
$29.88 (99.20%)
$70
8 months 13 days ago
(04-Mar-2026)
7/9 (77.78%)
$20.78 (52.98%)
324
What is HROW (Harrow Health) average time for price targets to be met?
Which analyst most recently updated their price target on HROW (Harrow Health)?
Which analyst has the most public recommendations on HROW (Harrow Health)?
Which analyst is the currently most bullish on HROW (Harrow Health)?
Which analyst is the currently most reserved on HROW (Harrow Health)?